Citations

Showing 10 of 108119 citations.

Lavender Aromatherapy to Reduce Anxiety During Intrauterine Insemination: A Randomized Controlled Trial
Jones, T.L., Purdy, MacKenzie P., Cutshall, Susanne M. , Hathcock, Matthew , Mahapatra, Saswati , Bauer, Brent A. , Jones, Tiffanny, Purdy, MacKenzie, Mahapatra, Saswati , Bauer, Brent A , Ainsworth, Alessandra J. , Stewart, Elizabeth A.

Mayo Clinic

Global Advances in Health and Medicine | November 17, 2021 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/21649561211059074 | PMID 34820153 Get It

Background Infertility is a global public health issue. Therapies such as intrauterine insemination (IUI) are effective but may be associated with considerable anxiety. Preliminary data suggest that decreasing this anxiety might lead to improved outcomes. Objective To determine whether lavender aromatherapy (LA) reduces anxiety during an IUI procedure. Methods A randomized controlled trial of women undergoing IUI at a hospital-based fertility clinic. The intervention and comparison were the use of LA vs water. Measurements were the change in anxiety level during an IUI procedure, with secondary assessment of pain scores, patient satisfaction, and pregnancy rates. Results In total, 67 women were screened, and 62 women randomly assigned to either placebo (n = 31) or LA (n = 31). No differences were observed in baseline demographic characteristics or visual analog scores for anxiety before IUI (mean [95% CI], 33.9 [25.2 to 45.6] mm vs 41.0 [33.0 to 49.0] mm) in the LA and placebo groups. However, a statistically significant change in anxiety was observed after LA inhalation during the procedure (mean [95% CI], −11.2 [−19.1 to −3.2]) compared with placebo (mean [95% CI], 1.3 [−5.6 to 8.2]; P = .02). No significant difference was observed in pain during IUI in the LA group vs placebo group. Patient satisfaction was high, with 93% of respondents in the LA group satisfied with the aromatherapy during their procedure. Additionally, 76% of participants who received placebo reported that they would prefer to use LA during their IUI. No statistically significant difference was detected in pregnancy rates between the 2 groups: 19.4% with LA vs 9.7% with placebo ( P = .47). Conclusion LA reduced anxiety and was preferred by women during IUI fertility treatments.
Evaluation and treatment of headache associated with moyamoya disease – a narrative review
Chiang, Chia‐Chun , Shahid, Adnan Hussain , Harriott, Andrea M. , Tietjen, Gretchen E. , Klaas, James P. , Shahid, Adnan H , Savastano, Luis E., Chiang, Chia-Chun , Savastano, Luis , Lanzino, Giuseppe

Mayo Clinic

Cephalalgia | November 17, 2021 | Volume: 42 | Issue: 6 | Pages: 542-552

10.1177/03331024211056250 | PMID 34786968 Get It

Background Headache in patients with moyamoya disease is an under-addressed topic in the medical literature. Delay in the diagnosis of moyamoya disease or inappropriate treatment of headache could lead to devastating cerebrovascular outcome. With the evolving understanding of moyamoya disease, migraine pathophysiology, and various migraine-specific medications that have become available, it is crucial to provide an updated overview on this topic. Methods We searched PubMed for keywords including moyamoya disease, moyamoya syndrome, headache in moyamoya, surgical revascularization, surgical bypass, migraine and moyamoya, and calcitonin gene-related peptide (CGRP). We summarized the literature and provide a comprehensive review of the headache presentation, possible mechanisms, the impact of various surgical revascularizations on headache in patients with moyamoya disease, and the medical management of headache incorporating novel migraine-specific treatments. Results and conclusion: The most common headache phenotype is migraine; tension-type headache, hemiplegic migraine, and cluster headache have also been reported. Most patients experience improvement of headache after surgical revascularization, though some patients report worsening, or new-onset headache after surgery. Given the complexity of moyamoya disease, careful consideration of different types of medical therapy for headache is necessary to improve the quality of life while not increasing the risk of adverse cerebrovascular events. More prospective studies are warranted to better understand and manage headache in patients with moyamoya disease.
Medicare and telehealth: The impact of COVID‐19 pandemic
Hamadi, Hanadi , Zhao, Mei , Haley, D. Rob , Dunn, Ajani N., Paryani, S B, Spaulding, Aaron , Hamadi, Hanadi Y , Haley, Donald Rob , Dunn, Ajani, Spaulding, Aaron

Mayo Clinic

Journal of Evaluation in Clinical Practice | November 17, 2021 | Volume: 28 | Issue: 1 | Pages: 43-48

10.1111/jep.13634 | PMID 34786796 Get It

AbstractStudy RationaleThe swift progression of the COVID‐19 pandemic appeared to facilitate the increase in telehealth utilization. However, it is clear neither how telehealth was offered by providers nor how it was used by patients during this time of unusual and rapid change within the health industry.AimTo investigates the telehealth utilization patterns of Medicare beneficiaries during the height of the COVID‐19 pandemic.Methods and MaterialsA cross‐sectional study design was used to examine the responses of 9686 Medicare beneficiaries to the Centers for Medicare and Medicaid Services (CMS) Medicare Current Beneficiary Survey, Fall 2020 COVID‐19 Supplement. Multiple logistic regression analyses were conducted to examine the relationship between telehealth offering and beneficiaries' sociodemographic variables.ResultsOver half (58%) of primary care providers provided telehealth services, while only 26%–28% of specialists did. Less than 8% of Medicare beneficiaries reported that they were unable to obtain care because of COVID‐19.ConclusionsThis research found that changes in Medicare policy, associated with CMS' declaration of telehealth waivers during the Public Health Emergency (PHE), likely increased the proliferation and utilization of telehealth services during the COVID‐19 pandemic, providing important access to care for certain populations. With the impending conclusion of the PHE, policymakers must 1) ascertain which elements of the new telehealth landscape will be retained, 2) modernize the regulatory, accreditation and reimbursement framework to maintain pace with care model innovation and 3) address disparities in access to broadband connectivity with a particular focus on rural and underserved communities.
Migrainous infarction of the eye: Two cases of monocular ischemic complications associated with retinal migraine
Chhabra, Nikita , Chiang, Chia‐Chun , Nome, Marie A. Di , Houghton, Odette M. , Carlin, Rachel E, O’Carroll, Cumara B. , Dumitrașcu, Oana , Di Nome, Marie A, Houghton, Odette, Chiang, Chia-Chun , Dodick, David W.

Mayo Clinic

Cephalalgia | November 17, 2021 | Volume: 42 | Issue: 6 | Pages: 553-556

10.1177/03331024211056286 | PMID 34786973 Get It

Background Retinal migraine is defined by fully reversible monocular visual phenomena. We present two cases that were complicated by permanent monocular vision deficits. Cases A 57-year-old man with history of retinal migraine experienced persistent monocular vision loss after one stereotypical retinal migraine, progressing to finger-count vision over 4 days. He developed paracentral acute middle maculopathy that progressed to central retinal artery occlusion. A 27-year-old man with history of retinal migraine presented with persistent right eye superotemporal scotoma after a retinal migraine. Relative afferent pupillary defect and superotemporal visual field defect were noted, consistent with ischemic optic neuropathy. Conclusion Retinal migraine can complicate with permanent monocular visual loss, suggesting potential migrainous infarction of the retina or optic nerve. A thorough cerebrovascular evaluation must be completed, which was unrevealing in our cases. Acute and preventive migraine therapy may be considered in retinal migraine patients, to mitigate rare but potentially permanent visual loss.
Patients Use Fewer Opioids Than Prescribed After Arthroscopic Release of Elbow Contracture: An Evidence‐Based Opioid Prescribing Guideline to Reduce Excess
Liévano, Jorge Rojas , Rotman, Dani , Shields, Maegan N. , Sánchez‐Sotelo, Joaquín , Shukla, Dave R. , Olson, Tammy S. , Vaichinger, Anthony M. , O’Driscoll, Shawn W. , Rojas Lievano, Jorge, Sanchez-Sotelo, Joaquin, Fitzsimmons, James S. , O'Driscoll, Shawn W., Sanchez-Sotelo, J. , Fitzsimmons, James S , Morrey, Mark E. , Olson, Tammy, Lievano, Jorge Rojas , Shukla, Dave R.

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | November 17, 2021 | Volume: 3 | Issue: 6 | Pages: No page available

10.1016/j.asmr.2021.09.002 | PMID 34977643 Get It

Purpose To generate an evidence‐based opioid‐prescribing guideline by assessing the pattern of total opioid consumption and the factors that may predict opioid consumption following arthroscopic release of elbow contracture and to investigate whether the use of continuous passive motion (CPM), as compared to physical therapy (PT), was associated with a decrease in pain and opioid consumption after arthroscopic release of elbow contracture. Methods Data collected from a randomized controlled trial that compared continuous passive motion (CPM) ( n = 24) to physical therapy (PT) ( n = 27) following arthroscopic release of elbow contracture was analyzed for opioid use. Fifty‐one participants recorded their daily opioid consumption in a postoperative diary for 90 days. Multivariate analysis was performed to identify factors associated with opioid use. Recommended quantities for postoperative prescription were generated using the 50th percentile for patients without and the 75th percentile for patients with factors associated with higher opioid use. Results The median total opioid prescription was 437.5‐mg morphine milligram equivalents (MMEs) (58 pills of 5 mg oxycodone) and the median total opioid consumption was 75 MMEs (10 pills of 5‐mg oxycodone). Twenty‐two percent of patients took no opioid medication, 53% took ≤10 pills, 69% took ≤20 pills and 75% took ≤30 pills. Predictors of higher opioid use were preoperative opioid use, age <60 years and inflammatory arthritis. The total opioid consumption appeared similar between the CPM and the PT group. Seventy‐five percent of patient’s home opioid requirements would be satisfied using the following guideline: Patients undergoing contracture release for osteoarthritis or post‐traumatic contracture should be given a prescription for 10 pills of 5 mg oxycodone or its equivalent at discharge. Patients with inflammatory conditions or those taking preoperative opioids should be prescribed 30 pills of 5 mg oxycodone or its equivalent. Conclusion This study suggests that most patients undergoing arthroscopic release of elbow contracture use relatively few opioid pills after surgery. Use of an evidence‐based guideline could decrease opioid prescriptions substantially, while still effectively treating patients’ pain.
ARMADA: Assessing reliable measurement in Alzheimer’s disease and cognitive aging project methods
Weıntraub, Sandra , Karpouzian‐Rogers, Tatiana , Peipert, John Devin , Nowinski, Cindy J. , Slotkin, Jerry , Wortman, Katy, Ho, Emily , Rogalskı, Emily , Carlsson, Cynthia M. , Lucas, John A. , Salmon, David P. , Snitz, Beth E. , Riley, Michaela , Eldes, Fatima, Ustsinovich, Vitali , Lucas, John, Peipert, John Devin , Giordani, Bruno , Goldstein, Felicia C. , Manly, Jennifer J. , Rentz, Dorene M. , Dodge, Hiroko Hayama , Gershon, Richard C

Mayo Clinic

Alzheimer's & Dementia | November 17, 2021 | Volume: 18 | Issue: 8 | Pages: 1449-1460

10.1002/alz.12497 | PMID 34786833 Get It

AbstractIntroductionEarly detection of cognitive decline in older adults is a public health priority. Advancing Reliable Measurement in Alzheimer's Disease and Cognitive Aging (ARMADA), a multisite study, is validating cognition, emotion, motor, and sensory modules of the National Institutes of Health Toolbox for Assessment of Neurological and Behavioral Function (NIHTB) in the aging spectrum from cognitively normal to dementia of the Alzheimer's type (DAT).MethodsParticipants 65 to 85 years old, in demographic groups racially proportional to the general US population, are recruited in one of three groups to validate the NIHTB: cognitively normal, amnestic mild cognitive impairment (aMCI), or mild DAT. Additional special emphasis cohorts include (1) Blacks in the three clinical groups; (2) Spanish‐speakers in the three clinical groups; (3) cognitively normal, population‐proportional, over age 85.DiscussionLongitudinal study will determine whether NIHTB can predict cognitive decline and is associated with Alzheimer's disease biomarkers. Here, we detail the methods for the ARMADA study.
The association of motoric cognitive risk with incident dementia and neuroimaging characteristics: The Atherosclerosis Risk in Communities Study
Gómez, Gabriela , Gabriel, Kelley Pettee , Palta, Priya, Gross, Alden L. , Soldan, Anja , Albert, Marilyn , Sullivan, Kevin , Jack, Clifford R. , Windham, B. Gwen , Jack, Clifford R , Sullivan, Kevin J , Gottesman, Rebecca F. , Knopman, David S. , Walker, Keenan A.

Mayo Clinic

Alzheimer's & Dementia | November 17, 2021 | Volume: 18 | Issue: 3 | Pages: 434-444

10.1002/alz.12412 | PMID 34786837 Get It

AbstractIntroductionMotoric cognitive risk (MCR), a clinical syndrome characterized by slow gait speed and subjective cognitive complaints, has been associated with dementia risk. The neuropathological features underlying MCR remain poorly understood.MethodsThe Atherosclerosis Risk in Communities (ARIC) community‐based cohort study classified participants using standardized criteria as MCR+/– and mild cognitive impairment (MCI)+/– at study baseline (2011–2013). We examined the 5‐year dementia risk and baseline brain structural/molecular abnormalities associated with MCR+ and MCI+ status.ResultsOf 5023 nondemented participants included, 204 were MCR+ and 1030 were MCI+. Both MCR+ and MCI+ participants demonstrated increased dementia risk. The pattern of structural brain abnormalities associated with MCR+ differed from that of MCI+. Whereas MCI+ was associated with comparatively smaller volumes in brain regions vulnerable to Alzheimer's disease pathology, MCR+ status was associated with smaller volumes in frontoparietal regions and greater white matter abnormalities.DiscussionMCR may represent a predementia syndrome characterized by prominent white matter abnormalities and frontoparietal atrophy.
Carotid Plaques From Symptomatic Patients With Mild Stenosis Is Associated With Intraplaque Hemorrhage
Nardi, Valentina , Benson, John C. , Bois, Melanie C. , Saba, Luca , Larson, Anthony S. , Ӧzcan, Ilke , Ahmad, Ali , Morse, David , Meyer, Fredric B. , Brinjikji, Waleed , Lerman, Lilach O. , Benson, John , Ozcan, Ilke , Morse, David W, Lanzino, Giuseppe , Lerman, Lilach O , Savastano, Luis E., Lerman, Amir , Larson, Anthony , Morse, David , Nardi, Valentina , Saba, Luca , Lanzino, Giuseppe , Savastano, Luis , Lerman, Amir

Mayo Clinic

Hypertension | November 17, 2021 | Volume: 79 | Issue: 1 | Pages: 271-282

10.1161/hypertensionaha.121.18128 | PMID 34878895 Get It

Carotid plaque vulnerability features beyond the degree of stenosis may play a key role in the pathogenesis and recurrence of ischemic cerebrovascular events. This study sought to compare intraplaque hemorrhage (IPH) as a marker of plaque vulnerability in symptomatic patients with mild (<50%), moderate (50%–69%), and severe (≥70%) carotid artery stenosis. We included patients who experienced ischemic cerebrovascular events with no other identifiable sources and underwent carotid endarterectomy for mild (n=32), moderate (n=47), and severe (n=58) carotid artery stenosis. The degree of stenosis and imaging hallmarks were assessed by computed tomography angiography or magnetic resonance angiography. Plaque specimens were stained with hematoxylin and eosin and Movat pentachrome staining. Carotid plaques of patients with mild stenosis had a higher extent of IPH (%) on tissue analysis compared with patients with moderate (mild, 15.7% [interquartile range, 7.8%–26.7%]; moderate, 3.9% [0.0%–9.2%]; P <0.001) and severe carotid artery stenosis (mild, 15.7% [interquartile range, 7.8%–26.7%]; severe, 2.5% [interquartile range, 0.0%–11.2%]; P <0.001). When considering the degree of carotid artery stenosis as a continuous variable, a lower lumen narrowing was associated with higher extent of IPH ( P <0.001; R, −0.329). Our major finding is the association of IPH with mild carotid artery stenosis based on histological analysis. The current study may suggest that IPH potentially plays a role in the mechanism of stroke in patients with nonobstructive carotid stenosis.
A Real-world Experience of Atrioventricular Synchronous Pacing with Leadless Ventricular Pacemakers
Kowlgi, Gurukripa N. , Tempel, Nathan D., Henrich, Mark, Venkatachalam, Kalpathi L., Scott, Luis R. , Shen, Win‐Kuang , Deshmukh, Abhishek , Madhavan, Malini , Lee, Hon-Chi , Friedman, Paul A. , Cha, Yong‐Mei , Mulpuru, Siva K. , Kowlgi, Narayan G , Tseng, Andrew S. , Asirvatham, Samuel J.

Mayo Clinic

No container title available | November 16, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.163711930.05423871/v1 Get It

Aims: The MicraTM transcatheter pacing system (TPS) (Medtronic) is the only leadless pacemaker that promotes atrioventricular (AV) synchrony via accelerometer-based atrial sensing. Data regarding the real-world experience with this novel system are currently lacking. We sought to characterize patients undergoing MicraTM -AV implants, describe percentage AV synchrony achieved, and analyze the causes for suboptimal AV synchrony. Methods: In this retrospective cohort study, electronic medical records from 56 consecutive patients undergoing MicraTM -AV implants at the Mayo Clinic sites in Minnesota, Florida, and Arizona with a minimum follow-up of 3 months were reviewed. Demographic data, comorbidities, echocardiographic data, and clinical outcomes were compared among patients with and without atrial synchronous-ventricular pacing (AsVP) ≥70%. Results: Fifty-six percent of patients achieved AsVP ≥70%. Patients with adequate AsVP had smaller body mass indices, a lower proportion of congestive heart failure and pulmonary hypertension. Echocardiographic parameters and procedural characteristics were similar across the two groups. Active device troubleshooting was associated with higher AsVP. The likely reasons for low AsVP were persistent atrial arrhythmias, small A4-wave amplitude, and inadequate device reprogramming. Importantly, in patients with low AsVP, subjective clinical worsening was not noted during follow-up. Conclusion: With the increasing popularity of leadless PM, it is paramount for device implanting teams to be familiar with common predictors of AV synchrony and troubleshooting with MicraTM -AV devices.
Toward Real-Time, At-Home Patient Health Monitoring Using Reservoir Computing CMOS IC
Chandrasekaran, Sanjeev Tannirkulam , Bhanushali, Sumukh Prashant , Banerjee, Imon , Sanyal, Arindam , Banerjee, Imon

Mayo Clinic

IEEE Journal on Emerging and Selected Topics in Circuits and Systems | November 16, 2021 | Volume: 11 | Issue: 4 | Pages: 829-839

10.1109/jetcas.2021.3128587 Get It